Accurate diagnosis and appropriate treatment of acute bacterial rhinosinusitis: Minimizing bacterial resistance

Clinical Therapeutics

Volumn 25, Issue 7, 2003, Pages 1936-1951

  Garau, Javier ^a   Dagan, Ron ^b,c  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

ABRS; Acute bacterial rhinosinusitis; Antibiotics; Resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFDINIR; CEFPODOXIME; CEFPODOXIME PROXETIL; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; COTRIMOXAZOLE; DECONGESTIVE AGENT; DOXYCYCLINE; ERYTHROMYCIN; EXPECTORANT AGENT; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAFURAZOLE;

ACUTE DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DIAGNOSTIC ACCURACY; DISEASE DURATION; DISEASE SEVERITY; DRUG CHOICE; EVIDENCE BASED MEDICINE; HUMAN; INFECTION RISK; PATHOGENESIS; PRACTICE GUIDELINE; REVIEW; RHINOSINUSITIS; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

EID: 0042202004     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)80197-2     Document Type: Article

References (47)

1. Block SL, Harrison CJ, Hedrick JA, et al Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J. 1995;14:751-759.
2. Dowell SF, Schwartz B. Resistant pneumococci: Protecting patients through judicious use of antibiotics Am Fam Physician 1997;55:1647-1658.
3. Jacobs RF. Judicious use of antibiotics for common pediatric respiratory infections. Pediatr Infect Dis J. 2000;19:938-943.
4. Seppala H, Klaukka T, Vuopio-Varkila J, et al, for the Finnish Study Group for Antimicrobial Resistance The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med. 1997;337:441-446.
5. Dowell SF, Schwartz B, Phillips WR, for the Pediatric URI Consensus Team. Appropriate use of antibiotics for URIs in children: Part I Otitis media and acute sinusitis. Am Fam Physician. 1998;58:1113-1118, 1123.
6. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Executive summary Otolaryngol Head Neck Surg. 2000;123:1-4
7. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: Contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol. 1999;103:408-414.
8. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-219
9. Nash DR, Harman J, Wald ER, Kelleher KJ. Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. Arch Pediatr Adolesc Med 2002;156:1114-1119
10. Gwaltney JM Jr. Sinusitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 5th ed. Philadelphia: Churchill Livingstone; 2000:676-686.
11. Poole MD. A focus on acute sinusitis in adults: Changes in disease management. Am J Med. 1999;106:38S-47S.
12. Gwaltney JM Jr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and anti-microbial therapy of adults with acute community-acquired sinusitis: A fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol. 1992;90:457-461.
13. Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci. 1998;316:13-20.
14. Sokol W. Epidemiology of sinusitis in the primary care setting: Results from the 1999-2000 Respiratory Surveillance Program. Am J Med. 2001;111(Suppl 9A):19S-24S.
15. Musher DM, Bartlett JG, Doern GV. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. Arch Intern Med. 2001;161:2538-2544.
16. Chambers HF. Antimicrobial agents. In: Hardman JG, Limbird LE, eds. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 2001:1143-1170.
17. Peric M, Bozdogan B, Jacobs MR, Appelbaum PC. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother 2003;47:1017-1022.
18. Jacobs MR. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr Infect Dis J. 2000;19(Suppl 5):S47-S55.
19. Cunha BA. Clinical relevance of penicillin-resistant Streptococcus pneumoniae. Semin Respir Infect. 2002;17:204-214.
20. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:1208-1213.
21. Hyde TB, Gay K, Stephens DS, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA. 2001;286:1857-1862.
22. Felmingham D, Gruneberg RN. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother. 2000;45:191-203.
23. Adam D. Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother. 2002;50(Suppl):1-5.
24. Hamory BH, Sande MA, Sydnor A Jr, et al. Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis. 1979;139:197-202.
25. Vogan JC, Bolger WE, Keyes AS. Endoscopically guided sinonasal cultures: A direct comparison with maxillary sinus aspirate cultures. Otolaryngol Head Neck Surg. 2000; 122:370-373.
26. Centers for Disease Control and Prevention. Antimicrobial resistance resource page. Available at: http://www.cdc.gov/ncidod/dbmd/antibiotic-resistance/htm. Accessed July 20, 2000.
27. Morris P, Leach A. Antibiotics for persistent nasal discharge (rhinosinusitis) in children. Cochrane Database Syst Rev. 2002;CD001094.
28. Williams JW Jr, Simel DL, Roberts L, Samsa GP. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Intern Med. 1992;117:705-710.
29. Lindbaek M, Hjortdahl P. The clinical diagnosis of acute purulent sinusitis in general practice - a review. Br J Gen Pratt. 2002;52:491-495.
30. Hueston WJ, Eberlein C, Johnson D, Mainous AG III. Criteria used by clinicians to differentiate sinusitis from viral upper respiratory tract infection. J Fam Pract. 1998;46:487-492.
31. O'Brien KL, Dowell SF, Schwartz B, et al. Acute sinusitis - principles of judicious use of antimicrobial agents. Pediatrics. 1998;101(Suppl):174-177.
32. Wald ER. Sinusitis in children. N Engl J Med. 1992;326:319-323.
33. American Academy of Pediatrics, Subcommittee on Management of Sinusitis and Committee on Quality Improvement. Clinical practice guideline: Management of sinusitis. Pediatrics. 2001;108:798-808.
34. Ioannidis JP, Lau J. Technical report: Evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children: A systematic overview. Pediatrics. 2001;108:E57-E64.
35. Brook I, Gooch WM III, Jenkins SG. Medical management of acute bacterial sinusitis. Recommendations of a clinical advisory committee on pediatric and adult sinusitis. Ann Otol Rhinol Laryngol. 2000;182(Suppl):2-20.
36. Gwaltney JM Jr, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med. 1994;330:25-30.
37. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33:757-762.
38. Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA. 2003;289:719-725.
39. Vriens M, Blok H, Fluit A, et al. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: A 10-year survey. Eur J Clin Microbiol Infect Dis. 2002;21:782-786.
40. van Buchem FL, Knottnerus JA, Schrijnemaekers VJ, Peeters MF. Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet. 1997;349:683-687.
41. Ioannidis JP, Chew P, Lau J. Standardized retrieval of side effects data for meta-analysis of safety outcomes. A feasibility study in acute sinusitis. J Clin Epidemiol. 2002;55:619-626.
42. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The "Pollyanna phenomenon." J Pediatr. 1992;120:72-77.
43. Pfaller MA, Ehrhardt AF, Jones RN. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the Respiratory Surveillance Program Study: Microbiology from the medical office practice environment. Am J Med. 2001;111(Suppl 9A):4S-12S.
44. Kaliner M. Medical management of sinusitis. Am J Med Sci. 1998;316:21-28.
45. Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis. 1996;23:1209-1223.
46. Werning JW, Preston TW, Khuder S. Physician specialty is associated with differences in the evaluation and management of acute bacterial rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2002;128:123-130.
47. Gehanno P, Beauvillain C, Bobin S, et al. Short therapy with amoxicillin-clavulanate and corticosteroids in acute sinusitis: Results of a multicentre study in adults. Scand J Infect Dis. 2000;32:679-684.